Compounds > crisnatol
Page last updated: 2024-08-24

crisnatol and Neoplasms

crisnatol has been researched along with Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cobb, P; Drengler, R; Eckhardt, SG; Kraynak, M; Kuhn, J; Petit, T; Rowinsky, EK; Santabarbara, P; Simmons, C; Villalona-Calero, MA; Von Hoff, DD1
Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR1
Cobb, PW; Craig, JB; Harman, GS; Havlin, KA; Koeller, J; Kuhn, JG; Luther, JS; Turner, JN; Tweedy, DA; Weiss, GR1
Baker, LH; Chabot, GG; Lucas, S; Poplin, EA; Tuttle, RL; Wargin, WA1
Craig, JB; Harman, GS; Koeller, J; Kuhn, JG; Lucas, VS; Luther, JS; Turner, JN; Tuttle, RL; Tweedy, DA; Weiss, GR1

Reviews

1 review(s) available for crisnatol and Neoplasms

ArticleYear
New anticancer agents.
    Cancer chemotherapy and biological response modifiers, 1991, Volume: 12

    Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate

1991

Trials

3 trial(s) available for crisnatol and Neoplasms

ArticleYear
A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Chrysenes; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Propylene Glycols; Pulmonary Embolism; Thrombocytopenia

1999
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule.
    Selective cancer therapeutics, 1991,Summer, Volume: 7, Issue:2

    Topics: Aged; Antineoplastic Agents; Chrysenes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Nervous System Diseases; Propylene Glycols

1991
Crisnatol mesylate: phase I dose escalation by extending infusion duration.
    Investigational new drugs, 1991, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Chrysenes; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Propylene Glycols; Sarcoma

1991

Other Studies

1 other study(ies) available for crisnatol and Neoplasms

ArticleYear
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule.
    Cancer research, 1988, Aug-15, Volume: 48, Issue:16

    Topics: Adult; Aged; Antineoplastic Agents; Arrhythmias, Cardiac; Blood Pressure; Chrysenes; Digestive System; Drug Administration Schedule; Drug Evaluation; Electroencephalography; Female; Humans; Male; Middle Aged; Neoplasms; Nervous System; Phenanthrenes; Propylene Glycols

1988